Tibor Keler

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Regulatory T Cells

Top Venues

Cancer immunology, immunotherapy : CII

European journal of immunology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Lydia Bellmann, Helen Strandt, Claudia Zelle-Rieser, Daniela Ortner, Christoph H Tripp, Sandra Schmid, Julia Rühl, Annalisa Chiocchetti, Sandra Schaffenrath, Anastasia Prokopi, Sarah Spoeck, Athanasios Seretis, Barbara Del Frari, Stephan Sigl, Johanna Krapf, Christine Heufler, Tibor Keler, Christian Münz, Nikolaus Romani, Patrizia Stoitzner
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin. European journal of immunology 52 (11) (2022)
Bradley Alexander McGregor, Michael S Gordon, Ronan Flippot, Archana M Agarwal, Saby George, David I Quinn, Mark Rogalski, Thomas Hawthorne, Tibor Keler, Toni K Choueiri
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma. Investigational new drugs 38 (6) (2020)
Laura A Vitale, Li-Zhen He, Lawrence J Thomas, Anna Wasiuk, Thomas O'Neill, Jenifer Widger, Andrea Crocker, Laura Mills-Chen, Eric Forsberg, Jeffrey Weidlick, Colleen Patterson, Russell A Hammond, James Boyer, Crystal Sisson, Diego Alvarado, Joel Goldstein, Henry C Marsh, Tibor Keler
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Laura A Vitale, Lawrence J Thomas, Li-Zhen He, Thomas O'Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R Storey, Eric M Forsberg, Jeffrey Weidlick, April R Baronas, Lauren E Gergel, James M Boyer, Crystal Sisson, Joel Goldstein, Henry C Marsh, Tibor Keler
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy. Cancer immunology, immunotherapy : CII 68 (2) (2018)